The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold by Torii, K. (Kan) et al.
..
..
..
..
..
..
The impact of plaque type on strut
embedment/protrusion and shear stress
distribution in bioresorbable scaffold
Ryo Torii1†, Erhan Tenekecioglu2†, Yuki Katagiri3, Ply Chichareon3, Yohei Sotomi3,
Jouke Dijkstra4, Taku Asano3, Rodrigo Modolo3, Kuniaki Takahashi3, Hans Jonker5,
Robert van Geuns2, Yoshinobu Onuma2, Kerem Pekkan6, Christos V. Bourantas7,8,
and PatrickW. Serruys2,9*
1Department of Mechanical Engineering, University College London, London, UK; 2Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter,
Rotterdam, The Netherlands; 3Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 4LKEB-Division of Image
Processing, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands; 5Cardialysis, Rotterdam, The Netherlands; 6Department of Mechanical
Engineering, Koc University, Istanbul, Turkey; 7Institute of Cardiovascular Science, University College London, London, UK; 8Department of Cardiology, Barts Heart Centre,
London, UK; and 9Imperial College, London, UK
Received 22 November 2018; editorial decision 20 May 2019; accepted 22 May 2019; online publish-ahead-of-print 19 June 2019
Aims Scaffold design and plaque characteristics influence implantation outcomes and local flow dynamics in treated
coronary segments. Our aim is to assess the impact of strut embedment/protrusion of bioresorbable scaffold on
local shear stress distribution in different atherosclerotic plaque types.
...................................................................................................................................................................................................
Methods
and results
Fifteen Absorb everolimus-eluting Bioresorbable Vascular Scaffolds were implanted in human epicardial coronary
arteries. Optical coherence tomography (OCT) was performed post-scaffold implantation and strut embedment/
protrusion were analysed using a dedicated software. OCT data were fused with angiography to reconstruct
3D coronary anatomy. Blood flow simulation was performed and wall shear stress (WSS) was estimated in each
scaffolded surface and the relationship between strut embedment/protrusion and WSS was evaluated. There were
9083 struts analysed. Ninety-seven percent of the struts (n= 8840) were well-apposed and 243 (3%) were malap-
posed. At cross-section level (n= 1289), strut embedment was significantly increased in fibroatheromatous plaques
(76 ± 48mm) and decreased in fibrocalcific plaques (35 ± 52mm). Compatible with strut embedment, WSS was
significantly higher in lipid-rich fibroatheromatous plaques (1.50 ± 0.81 Pa), whereas significantly decreased in fibro-
calcified plaques (1.05 ± 0.91 Pa). After categorization of WSS as low (<1.0 Pa) and normal/high WSS (>_1.0 Pa),
the percent of low WSS in the plaque subgroups were 30.1%, 31.1%, 25.4%, and 36.2% for non-diseased vessel
wall, fibrous plaque, fibroatheromatous plaque, and fibrocalcific plaque, respectively (P-overall < 0.001).
...................................................................................................................................................................................................
Conclusion The composition of the underlying plaque influences strut embedment which seems to have effect on WSS.
The struts deeply embedded in lipid-rich fibroatheromas plaques resulted in higher WSS compared with the other
plaque types.
                                                                                                                                                                                                                   
Keywords atherosclerotic plaque • bioresorbable scaffold • strut embedment • strut protrusion • shear stress
Introduction
Temporary scaffolding of diseased vessels by bioresorbable scaffolds
(BRSs) were introduced to overcome the limitations of the metallic
stents. However, unprecedented relatively high thrombosis rates
have raised significant concerns about the efficacy of this technology.1
Late loss in the Absorb BRS was significantly larger than in the metal-
lic everolimus-eluting stent (EES) and device-oriented composite
* Corresponding author. Tel: þ31 (010) 206 2828; Fax: þ31 (010) 206 2844. E-mail: patrick.w.j.c.serruys@gmail.com
† The first two authors contributed as co-first author.
Published on behalf of the European Society of Cardiology. All rights reserved. VC The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
European Heart Journal - Cardiovascular Imaging (2020) 21, 454–462
doi:10.1093/ehjci/jez155
D
ow
nloaded from
 https://academ
ic.oup.com
/ehjcim
aging/article-abstract/21/4/454/5520594 by Erasm
us U
niversiteit R
otterdam
 user on 31 M
arch 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.
endpoint (cardiac death, target vessel myocardial infarction, and
clinically-indicated target lesion revascularization) at 3 years follow-
up was higher in Absorb than in metallic Xience (10% vs. 5%,
P= 0.043).1 In the meta-analysis of five randomized clinical trials2
comparing the Absorb and the EES has shown that post-procedural
minimal lumen diameter was a predictive factor for device throm-
bosis which emphasizes the role of aggressive implantation strategy
with high-pressure post-dilatation using intracoronary imaging techni-
ques to optimize scaffold expansion.3 Intracoronary imaging guided
BRS implantation assists in sizing the diseased vessel segment and ref-
erence vessel to avoid any mismatch between the diseased and
healthy reference vessel segments. To achieve strut embedment
without scaffold disruption and for accurate measurement of minimal
scaffold area and scaffold asymmetry, intracoronary imaging guiding is
indispensable.4
Stent/scaffold design has impact on the local flow dynamics in
treated vessel segment. This effect depends not only on the device
design but also the embedment/protrusion of the scaffold struts with-
in the vessel wall. Well-embedded struts induce less flow disruptions
with shorter flow separations, whereas increased strut protrusion
may cause flow turbulence and recirculation zones around the struts.
These disrupted flow areas yield low wall shear stress (WSS) trigger-
ing various pathobiological reactions in platelets and endothelial layer
of the vessel wall that may result in excessive neointimal hyperplasia.5
The histomorphometric properties of the treated vessel segments,
in particularly the underlying atherosclerotic plaque properties
determine strut apposition and penetration status.6
In the present study, we investigated the strut embedment/protru-
sion patterns in different plaque types treated with BRS and its effect
on the local WSS distribution in treated segments.
Methods
Patient population and study device
Fifteen patients implanted with an Absorb bioresorbable vascular scaffold
(Absorb, Abbott Vascular, USA), from the Absorb Cohort B2 first-in-
man study, were included in the present analysis. The selection criteria
for the cases were as follows; the OCT pullback should provide clear
imaging of the vessel lumen with scaffold struts, the treated segments
were relatively straight vessel segments to prevent any effect of
curvatures on the shear stress alterations, and the cases should have
two separate coronary angiograms with >25 angle between each other
for a 3D centreline extraction to be used in vessel reconstruction for
computational fluid dynamic (CFD) simulations. The Absorb is a polylac-
tide scaffold eluting an antiproliferative drug everolimus, with two pairs
of radiopaque markers at both ends of the scaffold.
OCT image acquisition and data analysis
OCT imaging was performed post-procedure in the treated coronary
arteries using a frequency domain OCT system (C7-XR OCT
Intravascular Imaging System; St. Jude Medical, St. Paul, MN, USA) that
was pull-backed at a speed of 20 mm/s. A non-occlusive flushing tech-
nique was implemented during the pullback by injection of angiographic
contrast medium for blood clearance.
The OCT data were analysed off-line using QCU-CMS software
(Medis Medical Imaging systems, Leiden, The Netherlands) at every
200mm interval in the scaffolded segment and at every 400mm in the
non-scaffolded segments. In scaffolded segment, in each OCT frame, the
plaque composition was defined as following: Lipid tissue was delineated
as a signal-poor region with poorly depicted borders and a fast drop-off
in OCT signal, whereas calcium was defined as a signal-poor zone with
sharply delineated borders and a gradual drop-off in OCT signal. OCT
frames illustrating the segments with no or little intimal thickening and
the typical three-layered structure of the intima, media, and adventitia
were considered as normal vessel wall. Fibrous plaque was characterized
as the tissue with a high backscattering and a relatively homogeneous
OCT signal. Fibroatheroma was specified as a lipid-rich pool with circum-
ferential extent >90 and fibrocalcific plaque, as a plaque that included
calcific tissue and no lipid or lipid tissue with a circumferential extent
<90. At ‘strut-level’ analysis, for each strut, the underlying tissue type
was defined. At ‘cross-section level’, the predominant plaque type was
determined when several plaque types were identified in one cross-
section on OCT.7–9 The eccentricity index was calculated as the ratio be-
tween the minimal and the maximal diameter of each cross-section on
OCT.10 Expansion index was defined in ‘device-level’ as minimum scaffold
area divided by mean reference area.9
Coronary angiograms were analysed using a semiautomated edge de-
tection system (CAAS QCA-2D system, Pie Medical Imaging BV,
Maastricht, the Netherlands) with the dye-filled catheter used for calibra-
tion purposes. In each scaffold, the largest balloon diameter at maximal in-
flation pressure during deployment or post-dilatation were recorded and
used to calculate the balloon/artery ratio (defined as: mean inflated bal-
loon diameter/mean reference vessel diameter). Acute absolute scaffold
recoil was calculated as the difference between the mean diameter of the
deployment/post-dilatation balloon in its highest pressure (A) and the
mean luminal diameter in the scaffolded segment at the end of the pro-
cedure (B). Acute percent scaffold recoil was defined as: A-B/A and
expressed as percentage.11,12 Acute luminal gain was defined as the differ-
ence between pre- and post-procedural minimum lumen diameter, as
assessed by quantitative coronary angiography (QCA).13
Embedment/protrusion analysis by OCT
For strut embedment/protrusion analysis, the embedment depths and
protrusion distances were measured semiautomatically implementing a
dedicated version of the QCU-CMS software (version 4.69, Leiden
University Medical Center, Leiden, The Netherlands). The embedment
analysis in OCT was performed in the scaffolded segment at every
200mm longitudinal interval using the methodology described previous-
ly.8 Frames were excluded from stent strut measurement if >30% of ves-
sel wall was not visible, in which case the next frame was selected for
analysis. Struts located at the ostium of a side-branch were excluded
from the embedment analysis. Distances were adjusted based on the
known thickness of the strut including the polymer coating. A scaffold
strut was considered malapposed if the axial distance between strut sur-
face and luminal surface was greater than the strut thickness including its
polymer coating. The reproducibility of embedment analysis for Absorb
was previously reported by Sotomi et al.8
Reconstruction of coronary artery anatomy
Three-dimensional reconstruction of the treated coronary artery was
performed using a validated methodology.14 The radiopaque markers
and the anatomical landmarks (i.e. side branches), identified both on angi-
ography and OCT, were used to define the segment of interest which
included the scaffolded segment and 5 mm proximal and distal non-
scaffolded edge segments. The OCT images demonstrating the segment
of interest, were analysed at a 200mm interval in the scaffolded segment
and 400mm interval in the remaining segment of interest. The flow area
was defined by the luminal borders in native vessel segments. In the
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scaffolded segments, the adluminal side of the struts and the lumen bor-
ders in the inter-strut areas delineated the flow area.15,16 In two orthog-
onal (>25) angiograms, the luminal borders and lumen centreline were
extracted and the lumen centrelines were used to generate 3D luminal
centreline to be the backbone of the segments of interest.14 The flow
area contours detected in OCT were mounted perpendicularly onto the
luminal centreline and anatomical landmarks (side-branches) were used
to estimate their orientation.14
Blood flow simulation
CFD techniques were implemented to process 3D models. A finite vol-
ume mesh was generated and numerical blood flow simulation was per-
formed. The WSS was estimated by solving the 3D Navier–Stokes
equations (ANSYS Fluent, Canonsburg, PA, USA).17 To examine the in-
fluence of scaffold design on the local haemodynamic forces, the mesh
density around the struts and at flow boundary near the vessel wall be-
tween the struts was increased so as to have average element edge of
30lm (equals to 1/5 of the strut thickness). Blood was treated as a
homogeneous, Newtonian fluid with a viscosity of 0.0035 Pas and a dens-
ity of 1050 kg/m3. A steady flow profile was implemented at the inflow of
the 3D models. Blood flow for each reconstruction was estimated by
measuring, in two angiographic projections, the number of frames
required for the contrast agent to pass from inlet to the outlet of the
reconstructed segment, the volume of the reconstructed segment and
the cine frame-rate.17 The arterial wall was considered to be rigid and
no-slip conditions were imposed at the scaffold surface and the recon-
structed luminal surface. At the outlet of the model, zero pressure
condition was implemented. WSS was calculated as the product of
blood viscosity and the gradient of blood velocity at the wall and strut
surface. WSS was measured in the native and the scaffolded segment
around the circumference of the lumen per 5 interval (sector)
and along the axial direction per 200 mm interval with the use of an in-
house algorithm.18,19
Statistical analysis
Numerical data are expressed as mean ± standard deviation or median
and interquartile range depending on their distribution which was tested
by Kolmogorov–Smirnov test. Continuous variables with normal and
non-normal distributions were compared using the Student’s t-tests and
the Mann–Whitney U tests, respectively. Categorical variables were com-
pared using the Pearson’s v2 test or Fischer’s exact test, as appropriate.
As the data in the study have multilevel structure and unbalanced design,
mixed linear model was used for the comparisons of continuous variables
in the cross-section level analysis; the model took into account the clus-
tered nature of >1 cross-sections from the same scaffold and >1 struts
from the same cross-section, which might result in unknown correlations
among measurements within the clusters. For WSS comparison between
the plaque types, the multilevel model was built with fixed-effects on
cross-sectional lumen area, embedment and protrusion distances with
random effects on patient ID and cross-section ID. All statistical tests
were two-tailed, and an a-level of 0.05 was used to determine statistical
significance. Analyses were performed using the statistical analysis pro-
gramme SPSS V.23 (SPSS Inc., Chicago, IL, USA).
Results
Fourteen patients (15 lesions: 9 left anterior descending coronary
arteries, 2 left circumflex and 4 right coronary arteries) were investi-
gated in the present study. All the study patients were treated with a
3.0 18 mm Absorb scaffold. Pre-dilatation was mandatory in
Absorb Cohort-B trial and performed in all cases. Post-dilatation was
left to operator’s discretion in the study protocol.16 Patient charac-
teristics are shown in Table 1. Procedural characteristics are demon-
strated in Table 2. QCA analysis post-implantation showed an acute
gain of 1.19± 0.33 mm and acute percent recoil (using mean lumen
diameter) of 7.6 ± 6.5%. Pre-implantation and post-implantation
QCA data are shown in Table 3.
.................................................................................................
Table 1 Baseline characteristics of the studied
population (N5 14, lesion515)
Age (years) 616 5
Male 9 (64)
Hypertension 9 (64)
Hypercholesterolaemia 11 (79)
Diabetes mellitus 0 (0)
Current smoking 5 (36)
Prior percutaneous coronary intervention 2 (14)
Prior myocardial infarction 2 (14)
Stable angina 11 (79)
Unstable angina 1 (7)
Silent ischaemia 0 (0)
Treated vessel
Left anterior descending artery 9 (60)
Left circumflex artery 2 (13)
Right coronary artery 4 (27)
Ramus intermedius 0 (0)
Values are expressed as mean ± standard deviation or n (%).
.................................................................................................
Table 2 Procedural characteristics
N5 14, L515
ACC/AHA lesion class
A 0% (0)
B1 67% (10)
B2 33% (5)
C 0% (0)
Pre-dilatation 100% (15/15)
Pre-dilatation pressure (atm) 11.67 ± 2.51
Diameter of scaffolds (mm) 3.00 ± 0.0
Expected scaffold diameter (mm) 3.30 ± 0.11
Total length of study devices (mm) 18.0 ± 0.0
Nominal scaffold area (mm2) 7.07 ± 0.0
Expected scaffold area (mm2) 8.54 ± 0.58
Deployment pressure (atm) 13.00 ± 3.01
Post-dilatation 60% (9)
Post-dilatation pressure (atm) 18.29 ± 5.06
Procedure complication 13% (2)
Clinical device success 100% (15/15)
Clinical procedure success 100% (15/15)
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OCTanalysis results
OCT results are summarized in Table 4. Ninety-seven percent of the
struts were well-apposed (n= 8840) to the vessel wall. There were
243 malapposed struts (3%). Post-implantation expansion-index was
0.98 ± 0.21. Post-implantation mean scaffold area was 7.54 ± 0.93 mm2
and in-scaffold mean lumen area was 7.43 ± 0.88 mm2, whereas mean
lumen area in proximal non-scaffolded edge segment was
7.50 ± 1.84 mm2 and mean luminal area in distal non-scaffolded edge
segment was 5.39 ± 1.62 mm2. Mean eccentricity index was
0.67 ± 0.053. Cross-section level analysis (n= 1289) showed that in
scaffolded segment, there is an inverse correlation between the me-
dian WSS and the eccentricity index (r: -0.363, P< 0.0001).
Embedment/protrusion results
At device level analysis, the strut protrusion distance was
113 ± 14mm. At cross-section level analysis, the protrusion distance
was 115 ± 42mm. There was a significant relationship between the
embedment depths and plaque types (Table 5, Figure 1). Struts over
the fibroatheromatous plaques, were significantly deeper embedded
than in other plaque types (Figure 2). Deployment/post-dilatation bal-
loon pressures were found to have a modest effect on embedment
depths (r= 0.28, P= 0.048). Similar to the embedment analysis, the
protrusion distances were also significantly related to the underlying
plaque types. Lowest strut protrusion was noted in lipid-rich fibroa-
theromas, whereas in fibrous and fibrocalcific plaques, the strut
protrusion was relatively higher (Table 5). The majority of the
malapposed struts (75%, n= 149) were detected in the fibrocalcific
group and the rest (n= 94) were in fibrous plaque group. All of the
malapposed struts were detected in one case including totally 26
cross-sections. The newly developed thrombus post-implantation
attached to the BVS struts without limiting the embedment analysis
on OCT. Balloon sizing and inflation pressure had no direct effect on
strut embedment, although high-pressure post-dilatation (>_20 atm)
resulted in numerically deeper embedment than low-pressure post-
dilatation. Balloon type did not present any significant effect on strut
embedment at pre-dilatation (P= 0.49) or post-dilatation (P= 0.25).
WSS results
CFD results demonstrated higher WSS in fibroatheromas in Absorb
(Figure 3). The lowest WSS values were documented in fibrous and
fibrocalcific plaques (Table 5). After classifying the WSS as low
(<1.0 Pa) and normal/high WSS (>_1.0 Pa), the percentages of low
WSS in different plaque groups were 30.1%, 31.1%, 25.4%, and 36.2%
for the healthy vessel wall, the fibrous plaque, the fibroatheromatous
plaque, and the fibrocalcific plaque, respectively (P-overall <0.001).
Overall, there was an inverse linear relationship between strut
protrusion distance and WSS (Figure 4). In all plaque types, there was
a negative correlation between strut protrusion and WSS, which
was pronounced in calcified plaques (r= -0.240, P< 0.01 in fibrous;
r= -0.218, P< 0.01 in fibroatheroma and r= -0.261, P< 0.01 in
fibrocalcific plaques).
Discussion
The main results of our study can be summarized as follows: (i) Strut
embedment/protrusion differed according to the underlying plaque
.................................................................................................
.................................................................................................
.................................................................................................
Table 3 Results of QCA analysis pre-procedural,
post-procedural, and at 5-year follow-up
Pre-procedure
Lesion length (mm) 9.81 ± 3.87
Pre-procedure reference vessel diameter (mm) 2.56 ± 0.31
Pre-procedure minimum lumen diameter (mm) 1.04 ± 0.24
Pre-procedure percent diameter stenosis (%DS) 58.91 ± 10.19
Dmax proximal (mm) 2.84 ± 0.30
Dmax distal (mm) 2.69 ± 0.29
Post-procedure
Mean lumen diameter, in-scaffold (mm) 2.63 ± 0.22
Reference lumen diameter (mm) 2.62 ± 0.23
Minimum lumen diameter, in-scaffold (mm) 2.23 ± 0.19
In-scaffold percent diameter stenosis (%DS) 15.09 ± 5.31
In-scaffold acute absolute gain (mm) 1.18 ± 0.31
In-scaffold acute percent gain (%) 43.71 ± 11.49
In-scaffold acute absolute recoil (using mean
lumen diameter) (mm)
0.21 ± 0.18
In-scaffold acute percent recoil (using mean
lumen diameter) (%)
7.64 ± 6.49
In-scaffold acute absolute recoil (using minimum
lumen diameter) (mm)
0.24 ± 0.17
In-scaffold acute percent recoil (using minimum
lumen diameter) (%)
9.69 ± 6.88
Ratio of post-dilatation balloon nominal diameter
to mean reference diameter
1.14 ± 0.08
Pre-dilatation balloon diameter RVD ratio 1.04 ± 0.15
.................................................................................................
Table 4 Results of post-procedural OCTanalysis
Post-procedural
In-scaffold mean lumen diameter (mm) 3.06 ± 0.21
In-scaffold minimum lumen diameter (mm) 2.75 ± 0.22
In-scaffold mean lumen area (mm2) 7.43 ± 0.88
In-scaffold minimum lumen area (mm2) 5.98 ± 0.96
Mean scaffold diameter (mm) 3.09 ± 0.19
Minimum scaffold diameter (mm) 2.80 ± 0.21
Mean scaffold area (mm2) 7.54 ± 0.93
Minimum scaffold area 6.19 ± 0.93
Post-procedure in-scaffold percent diameter
stenosis (%DS)
15.09 ± 5.31
Mean strut area (mm2) 0.20 ± 0.03
Mean lumen diameter in proximal edge segment (mm) 4.68 ± 0.32
Mean lumen area in proximal edge segment (mm2) 7.50 ± 1.84
Mean lumen diameter in distal edge segment (mm) 4.03 ± 1.23
Mean lumen area in distal edge segment (mm2) 5.39 ± 1.62
Eccentricity index 0.67 ± 0.05
Asymmetry index 0.23± 0.09
Expansion index 0.98 ± 0.21
Embedment and shear stress in bioresorbable scaffolds 457
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..type with an increased strut embedment in fibroatheromatous pla-
ques; (ii) The strut embedment/protrusion pattern had an evident im-
pact on WSS distribution: in fibroatheromas, where the struts were
deeply embedded, there were less flow disruptions resulting in rela-
tively higher WSS values compared with other plaque types; (iii)
There was an inverse linear relationship between strut protrusion
and WSS which was prominent in calcified plaques compared with
the other plaque types.
Despite breathtaking advances in stent/scaffold designs over the last
decades, restenosis and stent/scaffold thrombosis continue to be the
‘Achilles heel’ of the percutaneous coronary intervention (PCI).5 PCI
outcomes depend on several factors including implantation techniques,
treated vessel segment features, particularly plaque characteristics
and the design properties of the stent/scaffold. While the normal
vessel wall is incompressible, the diseased vessel wall, including athero-
sclerotic plaque, is compressible and exhibits viscoelasticity while
subjected to a pressure load.20,21 Based on this fact, stent/scaffold
strut design and plaque type seem to be the main factors for strut
penetration which determines local flow patterns, regulates neointimal
hyperplasia and may be coupled with thrombus formation.5
Figure 1 Rectangular shaped struts of Absorb BVS were automatically detected by QCU-CMS (v.14.9) after automatic detection of interpolated
luminal contour (blue contour represents embedment contour), protrusion/embedment distances were analysed semiautomatically using the meth-
odology described by Sotomi et al.8 The white arrows show the fibrous tissue in panel II, the lipid pool in panel III, and the calcified plaque in panel IV.
The struts were well-embedded in fibroatheromatous plaques, whereas fibrocalcific plaque prevents deep penetration of the struts. Most of the
malapposed struts (ms) were detected in vessel segments with calcified plaques.
....................................................................................................................................................................................................................
Table 5 Cross-section level embedment/protrusion andWSS according to the plaque type
Plaque type Embedment depth (mm) Protrusion distance (mm) WSS (Pa)
Non-atherosclerotic intimal thickening/normal vessel wall (n = 2275) 47 ± 34*,D,¥ 123 ± 34¶,:,p 1.44 ± 0.9h,§,£
Fibrous (n = 4191) 53 ± 40*,#,& 118 ± 38¶,w,‡ 1.24 ± 0.78a,h,‘
Fibroatheromatous (n = 2027) 76 ± 48#,
Þ
,D 94.6 ± 46 †,w,p 1.50 ± 0.81+,§,a
Fibrocalcific (n = 590) 35 ± 52&,
Þ
,¥ 139 ± 50‡,†,: 1.05 ± 0.91‘,£,+
For embedment: *P= 0.09, #P< 0.001, &P< 0.001,
Þ
P< 0.0001, DP< 0.0001, ¥P< 0.0001.
For protrusion: ¶P= 0.74, :P< 0.0001, pP< 0.0001, wP< 0.0001, ‡P< 0.0001, †P< 0.0001.
For WSS: hP< 0.001, §P= 0.06, £P< 0.0001, hP< 0.0001, 1P< 0.0001,
P
P< 0.0001.
n = total strut number in each plaque type; P-values come from mixed-effects regression analysis.
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Plaque type and strut embedment/
protrusion impact on local shear stress
The composition and morphology of the plaque determine its mech-
anical behaviours. The cellularity level and the tissue composition are
the main determinants of the stiffness of the atherosclerotic plaques.
Hypocellular plaques, such as fibrous and fibrocalcific plaques, are
one to two times stiffer than the cellular lipid-rich fibroatheromatous
plaques lipid-rich fibroatheromatous plaque is the most compliant
and least stiff plaque type.22,23 Mechanical testing of the human ath-
erosclerotic plaques unravelled that during compression–relaxation
cycles, fibrous and calcified plaques behave similarly and are stiffer
than the lipid-rich atheromatous plaques.24 Young’s modulus (elastic
modulus), indicates the resistance of a material to elastic deformation
of fibrotic plaques are two-times higher than lipid-rich
fibroatheromas.25
Stent/scaffold implantation imperils the vessel wall to higher
stresses that may injure the internal elastic lamina, induces smooth
muscle cell proliferation and neointimal tissue growth which may
conclude with in-stent/scaffold restenosis. The level of vessel wall in-
jury depends on stent/scaffold design, vessel geometry, curvature, im-
plantation pressures during the procedure and biomechanical
properties of the treated plaque. Under compressive load, particular-
ly lipid-rich plaques demonstrate viscoelastic behaviour that reflects
their relatively higher compliance. Furthermore, lipid-rich fibroather-
omatous plaques are less stiffer than non-diseased healthy vessel
wall.26 The stiffness of the vessel wall increases from lipid-rich athero-
mas to fibrotic and fibrocalcific lesions.27,28 In the present study, as
expected, the polymeric struts penetrated deeper in lipid-rich
atheromatous plaques than fibrous and fibrocalcific plaques, due to
the viscoelastic properties of these plaque types.
Vessel wall stiffness, determined by plaque phenotype, influences
scaffold expansion which has a potential impact on PCI outcomes.9 In
calcified lesions, vessel expansion is less than non-calcified lesions.29
During implantation, in calcified, stiff lesions, the presence of calcium
reduces the applied stress within the vessel wall that behaves as an
‘absorber’ protecting the vessel wall confronting high pressures.30
Implementing high pressures on cellular and compliant plaques may
cause immense injury in the vessel wall, whereas the protective role
of calcified plaque allows vessel dilatation at higher balloon pressures
more safely.31 Therefore, the same device with the same applied
pressures in different types of plaques will result in different levels of
tissue injury and luminal gain.23 In the present study, after adjusting
according to the plaque type, embedment/protrusion was slightly
related with deployment pressures.9
The endothelization of the denuded artery wall and strut surfaces
are related with local WSS.32 Low WSS induces neointimal growth
that covers the struts and inter-strut vessel wall area.18,33 Low shear
stress at the bottom beside the struts induces platelets and endothe-
lium aggregation in the disrupted flow zones and trigger several bio-
logical pathways for neointimal regeneration and thrombus
formation in the inter-strut zones.34 Flow separation and flow stagna-
tion zones induce confluent endothelial cells migration away from
the flow reattachment points demonstrated in flow chamber experi-
ments.35 Higher embedment with less protrusion provides less flow
disruption, yielded by non-low WSS in the vicinity of the struts that
protects the vessel wall biology.36 Lipid-rich fibroatheromas with
Figure 2 In the illustration, embedment distances were demonstrated for each group. Mean WSS for each group was shown in the lower OCT
cross-section panels. P-values come from mixed effects analysis for the comparison of embedment distances between plaque types. In lipid-rich
plaques, the struts embedment was deeper than in other plaque types.
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deeper embedded struts demonstrated more ‘favourable’ WSS mag-
nitudes, whereas stiffer fibrous and fibrocalcific plaques unravelled
relatively lower WSS due to the flow disturbances related to less
strut embedment. Well-embedded struts may reduce area with dis-
turbed ‘atheroprone’ low WSS which might have favourable effects
on vessel wall healing at follow-up post-implantation.
Figure 3 Representative OCT cross sections (left panels) with WSS contour overlay (right panels). Fibrous plaques were associated with higher
strut protrusion distances that induced very low WSS (shown by the color contour overlay) due to flow obstruction and the formation of recircula-
tion zones (A1, A2). Lipid-rich fibroatheromatous plaques allowed deeper strut embedment which induced less flow disruption in the vicinity of the
struts resulting in low WSS gradient between top of the struts and inter-strut zones (B1, B2). Due to poor penetration in non-compliant calcified pla-
ques, flow disruption induced higher gradients between the top of the struts and inter-strut zones (C1, C2). Small insert in each panel shows close-up
view around struts.
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Practical implications
The idea of designing lesion specific stent and implantation techniques
using intravascular imaging modalities has been a research subject.
Due to its higher strut thickness, Absorb potentially induces flow dis-
ruptions more than the stents/scaffolds with thinner strut
designs.37,38 However, in case of well-embedment, as in lipid-rich pla-
ques, Absorb may provide more ‘favourable’ shear stress distribution
due to deeper strut penetration which may potentially promote a
strategy of BRS implantation according to the underlying plaque type
and may mitigate the negative aspects of thicker strut and non-
streamline strut geometry.39
Limitations
The main limitation of the present study was low case number.
Several criteria were implemented for filtering suitable cases. To pre-
vent any effect of swirling-flow due to vessel curvature, on the scaf-
folded segment WSS distribution, we didn’t include the cases with
curvature and the cases without two angiographic projections at least
with >25 difference couldn’t be reconstructed. However, total strut
and cross-section numbers provided well-fitted statistical models for
getting reliable conclusions. The effect of low WSS at follow-up was
not evaluated in the present study, whereas such clinical inferences
can be exemplified from the literature.
Conclusion
Treated plaque type influences strut embedment/protrusion in the
vessel wall. OCT has high accuracy to detect calcified plaques with its
circumferential extent and depth, which are crucial information for
lesion preparation such as balloon pre-dilatation, debulking, etc.
Shear stress distribution is related with strut penetration in the vessel
wall. Following BRS implantation, embedment/protrusion analysis
may help to improve implantation process and local haemodynamic
forces, which may potentially influence neointimal hyperplasia and
thrombus formation.
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